← All trials
NCT04581356
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 21, 2020
- Primary completion
- Aug 20, 2021
- Completion date
- Sep 20, 2021
- First posted
- Oct 9, 2020
- Last posted
- Oct 12, 2020
- Enrollment
- 10
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Pediatric Specialists of VirginiaLead sponsor
- Global Blood Therapeutics, Inc.Collaborator
- University of California, San FranciscoCollaborator
- Mednax Center for Research, Education and QualityCollaborator
- Pediatric Specialists of VirginiaSponsor investigator
- Pediatric Specialists of VirginiaOverall official - principal investigator
- Pediatric Specialists of VirginiaStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.